PBM Stock Analysis: Buy, Sell, or Hold?
PBM - Psyence Biomedical Ltd. Common Shares
$5.40
0.43 (8.65%)
▲
5d:
+21.9%
30d:
+61.19%
90d:
+54.73%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 28, 2026
13d
Get Alerted When PBM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PBM is 15.6% above its trading range ($4.67). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PBM is 15.6% above its trading range ($4.67). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PBM is currently trading at $5.40, which is considered extended relative to its 30-day fair value range of $3.58 to $4.67.
Technical Outlook: Technically, PBM is in a downtrend. Immediate support is located at $4.10, while resistance sits at $5.63. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: PBM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PBM is in a downtrend. Immediate support is located at $4.10, while resistance sits at $5.63. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: PBM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.58 -
$4.67
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
11.8%
All Signals
- BEARISH: Price significantly overextended (+15.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.7%)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.58 -
$4.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.10
Resistance Level
$5.63
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Share & Embed Analysis
Last updated: September 13, 2026 11:09 PM ET
Data refreshes hourly during market hours. Next update: 12:09 AM
Data refreshes hourly during market hours. Next update: 12:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PBM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$849 | 50 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
